Client Overview A global biopharmaceutical company approached CSI to support a Phase III oncology study requiring Opdivo (nivolumab) as a comparator. The study spanned 4 countries across North America, Europe and Asia-Pacific, with a target enrolment of over 500 patients. The client’s main objective was to ensure timely delivery of branded Opdivo for multiple trial sites while maintaining transparent, full chain of custody and documentation.   Challenge There were several key

At CSI, we understand the urgency and precision required in ophthalmology research. Among the most pressing areas is wet age-related...

Strategy Partnerships for Budget Value As we enter Q4, many clinical operations teams face the familiar challenge of budget utilization....

Rare disease clinical trials present a distinct set of challenges that make sourcing strategies critical to study success. With fewer...

In the pharmaceutical industry, timelines serve as both operational benchmarks and market signals. When sponsors announce trial starts...

Rapid Supply of Abraxane in Europe Client Request: Urgent Need for Abraxane A global pharmaceutical sponsor was in a tight spot. They...

In an industry where both timelines and budgets are under constant pressure, clinical trial sponsors and CROs are often forced to balance...

We’re incredibly proud to announce that CSI has once again achieved the Platinum  EcoVadis  rating, for the second year in a row!  This...

In clinical trials, every element of the supply chain matters. From sourcing high-quality comparator drugs to managing timelines across...

Request A global listed Biotech company required large quantities of Eylea Pre-Filled Syringes (PFS)  sourced across both the EU and USA...

Client Request A leading global biopharmaceutical company approached CSI with an urgent need for the Fluarix QIV Southern Hemisphere...

CSI’s Strategic Approach to Mitigating Clinical Trial Supply Disruption Recent developments in U.S. trade policy are shaking up supply...

A Global Pharmaceutical Sponsor’s Challenge A global pharmaceutical sponsor conducting a Phase III clinical trial needed Semaglutide, a...

A Leading Biotech Client's Challenge A leading biotech client approached CSI to assist in sourcing the comparator drug Lucentis for a...

Clinical Services International is thrilled to be recognized as the Top Clinical Trial Services Provider 2024 by Life Sciences Review!...

CSI is excited to have our Managing Director Vanessa Dekou featured on the front cover of Life Sciences Magazine!  This recognition is...

Ensuring Efficiency, Compliance and Success Full supply chain management in clinical trial supply encompasses the comprehensive oversight...

CSI is extremely proud to announce our Platinum EcoVadis Award, signifying the highest level of recognition for corporate sustainability...

Ancillaries play a crucial role in ensuring the smooth execution of clinical trials, encompassing a broad range of items, materials and...